Version 1.0 of the Malaria Therapeutic Area User Guide (TAUG-Malaria) was developed under the CFAST Program and the CDISC Standards Development Process. TAUG-Malaria describes the most common biomedical concepts relevant to Malaria, and the necessary metadata to represent such data consistently with Terminology, CDASH, and SDTM.
An example CRF developed by the team can be accessed here: Malaria Case Record Form (CRF).
TA Standards extend the Foundational Standards to represent data that pertain to specific indications within disease areas. CDISC Standards specify how to structure the data; they do not specify what data should be collected or how to conduct clinical trials, assessments or endpoints.
Public Review Comments
CDISC posts Public Review comments and resolutions to ensure transparency and show implementers how comments were addressed in the standard development process.
TA Specifications show how to modify TAUG examples for various versions of the SDTM and SDTMIG. These specifications assist the FDA and the Japanese PMDA with testing to enable support of the standards and inclusion in their respective Technical Conformance Guides.1,2
The specifications comprise five worksheets in an Excel workbook:
A team from the Worldwide Antimalarial Resistance Network (WWARN), University of Oxford, and Infectious Diseases Data Observatory (IDDO) led by Dr. Laura Merson applied CDISC standards in field research data collection and aggregation leading to new treatment recommendations on how low-weight children suffering from malaria in sub-Saharan Africa are treated. These updated guidelines included increasing dosing for this pediatric weight class resulting in a reduction of mortality in these vulnerable patients.